Bourgeon Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Bourgeon Capital Management's LLY Position: Q2 2026 in Review
Bourgeon Capital Management increased its Eli Lilly (LLY) stake by 4.8% in Q2 2026, buying an estimated $1.15M and bringing the position to 24,426 shares worth $29.3M. The position accounts for 4.31% of the portfolio, ranked #2.
Bourgeon Capital Management first reported a position in LLY in Q3 2020 and has held it in 8 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Bourgeon Capital Management held 24,426 shares of Eli Lilly worth $29.3M as of Q2 2026.
- Bourgeon Capital Management bought 1,127 Eli Lilly shares in Q2 2026, an estimated $1.15M.
- Eli Lilly made up 4.31% of Bourgeon Capital Management's portfolio in Q2 2026, its #2 holding.
- Bourgeon Capital Management first reported a position in Eli Lilly in Q3 2020 and has held it in 8 quarters since.
- 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Bourgeon Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.